Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop.

11 Jan 2023

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

Researchers compared symptoms in patients with and without prior COVID-19 history and investigated symptoms associated with long COVID diagnosis in the UK.

11 Jan 2023

The decision of where to seek care is complicated by the multitude of options

One evening in February 2017, Sarah Dudley's husband, Joseph, started to feel sick. He had a high fever, his head and body ached, and he seemed disoriented, she said. The Dudleys had a decision to make: go to the hospital emergency room or to an urgent care clinic near their home in Des Moines, Iowa.

11 Jan 2023

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

University of North Florida Brooks College of Health faculty recently published a study showing dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates and can be an effective strategy to reduce the contagious respiratory disease burden during the winter.

10 Jan 2023

Fluid on the lungs associated with open water swimming

Fluid on the lungs, or pulmonary edema as it's formally known, is a relatively little known hazard associated with open water swimming, warn doctors in the journal BMJ Case Reports after treating a woman with the condition.

10 Jan 2023

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

A new initiative to better understand respiratory viruses has been launched today (10 January 2023) by the Wellcome Sanger Institute.

10 Jan 2023

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

A recent study published in the journal Scientific Reports examined the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole genome data to determine the deletion mutations around the spike protein region associated with increased transmission of the virus and identified an increase in the deletion-prone spike protein regions indicating an evolution strategy for immune escape.

9 Jan 2023

Compounds derived from B.C. sea sponge can prevent COVID-19 infection in human cells

UBC researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a B.C. sea sponge.

9 Jan 2023

Researchers study the spatial distribution of SARS-CoV-2 Omicron BA.1 variant in England

Researchers performed a genomic assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant’s BA.1 subvariant transmission in England.

9 Jan 2023

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

Europe is experiencing an increasingly large circulation of influenza and the respiratory syncytial virus (RSV).

9 Jan 2023

Researchers analyze targets of human T cell recognition against all coronaviruses

Researchers analyzed T cell reactivity against alpha and beta common cold coronaviruses (CoVs) [(CCC)] to inform the development of pan-CoV vaccine concepts.

9 Jan 2023

What was the prevalence of respiratory syncytial virus between August and December 2022?

Researchers presented the initial respiratory syncytial virus (RSV) surveillance findings for the period between August and December 2022.

9 Jan 2023

New model for detecting and estimating pathogen variant dynamics and risk

A recent study posted to the medRxiv* preprint server developed a hierarchical modeling method to estimate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant fitness advantage and prevalence.

8 Jan 2023

Clinical leaders, health experts and ministers convene in Downing Street for NHS Recovery Forum

Clinical leaders, health experts and ministers will convene in Downing Street for an NHS Recovery Forum today (Saturday 7 January).

6 Jan 2023

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

A new study aimed to analyze whether the order of immunization of vaccine types impacted the efficacy of a heterologous prime-boost vaccination strategy.

6 Jan 2023

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.

6 Jan 2023

The risk factors and outcomes of ARDS following infection with SARS-CoV-2 in a young adult population

Researchers evaluated the outcomes and identified risk factors associated with the development of ARDS after SARS-CoV-2 infections among young adults.

6 Jan 2023

New machine learning tool can shed light on chronic COVID symptoms

Long COVID has emerged as a pandemic within the pandemic. As scientists work to untangle the many remaining unanswered questions about how the initial infection impacts the body, they must now also investigate why some people develop debilitating, chronic symptoms that last months to years longer.

5 Jan 2023

Recently discovered protein holds potential for the development of new tests for infectious diseases

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA.

4 Jan 2023

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

A team from 15 U.S. medical centers led by UT Southwestern Simmons Cancer Center researchers has performed the first analysis of a potentially game-changing drug to treat upper urinary tract urothelial cancers.

4 Jan 2023

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Rethinking next generation of improved vaccines for mucosa-replicating viruses

Study suggests many symptoms are more common after COVID-19 infection, but only a few are commonly associated with a long COVID diagnosis

The decision of where to seek care is complicated by the multitude of options

Dual COVID-19 and seasonal influenza vaccinations are associated with reduced infection rates

Fluid on the lungs associated with open water swimming

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses

Deletions in the antigenic regions in SARS-CoV-2 increase transmission and immune evasion ability

Compounds derived from B.C. sea sponge can prevent COVID-19 infection in human cells

Researchers study the spatial distribution of SARS-CoV-2 Omicron BA.1 variant in England

Study reports COVID-19 vaccine hesitancy among 6.5% of the Spanish population

Researchers analyze targets of human T cell recognition against all coronaviruses

What was the prevalence of respiratory syncytial virus between August and December 2022?

New model for detecting and estimating pathogen variant dynamics and risk

Clinical leaders, health experts and ministers convene in Downing Street for NHS Recovery Forum

Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?

People with latent tuberculosis infection could be at a higher risk for cardiovascular disease

The risk factors and outcomes of ARDS following infection with SARS-CoV-2 in a young adult population

New machine learning tool can shed light on chronic COVID symptoms

Recently discovered protein holds potential for the development of new tests for infectious diseases

Study shows the potential of a game-changing drug to treat upper urinary tract urothelial cancers

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in